Defining Endoplasmic Reticulum Stress-Development Mitochondria Remodeling
定义内质网应激发育线粒体重塑
基本信息
- 批准号:10537152
- 负责人:
- 金额:$ 235.62万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-08-20 至 2025-06-30
- 项目状态:未结题
- 来源:
- 关键词:AcuteAlzheimer&aposs DiseaseApoptosisApoptoticBiochemicalBiologicalBiologyCardiolipinsCellsChronicComplexCrista ampullarisCryo-electron tomographyDevelopmentDiseaseEndoplasmic ReticulumEtiologyFrontotemporal DementiaGenetic TranscriptionGoalsGuanosine Triphosphate PhosphohydrolasesInner mitochondrial membraneLeadLinkMedical GeneticsMembraneMitochondriaMolecularMorphologyNerve DegenerationNeurodegenerative DisordersNeuronal DysfunctionOuter Mitochondrial MembraneOxidative PhosphorylationPathogenesisPathologicPhosphatidic AcidPhosphatidylethanolaminePhospholipidsProgressive Supranuclear PalsyProteinsRegulationRespirationSignal TransductionStressTauopathiesTestingTherapeuticTranslationsWorkarmattenuationcytochrome cendoplasmic reticulum stressimaging approachinsightmetabolomicsmitochondrial dysfunctionmitochondrial membraneproteostasisresponse
项目摘要
PROJECT SUMMARY
Endoplasmic reticulum (ER) stress and mitochondrial dysfunction are intricately linked in the onset and
pathogenesis of numerous neurodegenerative diseases such as Alzheimer’s disease (AD) and related
tauopathies including progressive supranuclear palsy (PSP) and frontotemporal dementia (FTD). However, the
pathologic relationship between ER stress and mitochondrial dysfunction in these diseases is currently poorly
defined. Clinical, genetic, and biochemical evidence shows that imbalanced signaling through the PERK arm of
the unfolded protein response (UPR) contributes to the neuronal dysfunction associated with many
neurodegenerative diseases including those listed above. PERK integrates transcriptional and translational
signaling to promote adaptive remodeling of mitochondrial proteostasis and function in response to acute ER
stress. However, in response to chronic ER stress, PERK initiates apoptosis through complex mechanisms that
involve mitochondrial dysfunction. This leads to the intriguing question: ‘How does PERK differentially regulate
protective and pathologic aspects of mitochondrial function in response to varying levels of ER stress?’. We
demonstrated that PERK-dependent translation attenuation promotes adaptive mitochondrial elongation in
response to acute ER insults. Here, we will show that this change in mitochondrial morphology corresponds to
PERK-dependent regulation of phospholipids within mitochondrial membranes. Intriguingly, changes in
phospholipids are implicated in the pathogenesis of multiple neurodegenerative diseases. Further, mitochondrial
phospholipids are key regulatory determinants for diverse aspects of mitochondrial biology including morphology,
oxidative phosphorylation, and apoptosis. Here, we test the hypothesis that PERK-dependent regulation of
mitochondrial phospholipids promotes adaptive remodeling of mitochondrial membranes during ER
stress and that imbalances in this regulation contributes to the pathologic mitochondrial dysfunction
observed during neurodegeneration. Using a combination of biochemical, metabolomic, and imaging-based
approaches, we will define the molecular basis for PERK-dependent regulation of mitochondrial phospholipids
and demonstrate the importance of this regulation in dictating mitochondrial morphology, cristae ultrastructure,
and function in response to ER stress. Through these efforts, we will identify PERK-dependent regulation of
mitochondrial phospholipids as a mechanism to adapt mitochondria in response to acute ER stress. Further, we
will show that chronic PERK signaling induces pathologic alterations to mitochondrial phospholipids that
contributes to the mitochondrial dysfunction associated with neurodegeneration. Collectively, our results will
establish PERK-dependent remodeling of mitochondrial membrane phospholipids as a key determinant in
dictating mitochondrial function in response to varying levels of ER stress. Further, our work will reveal new
insights into the pathologic and therapeutic implications of PERK signaling on the mitochondrial dysfunction
associated with the pathogenesis of neurodegenerative diseases including AD and related diseases.
项目概要
内质网(ER)应激和线粒体功能障碍在发病和发生过程中有着复杂的联系。
许多神经退行性疾病的发病机制,例如阿尔茨海默病(AD)和相关疾病
tau蛋白病包括进行性核上性麻痹(PSP)和额颞叶痴呆(FTD)。
目前,这些疾病中 ER 应激与线粒体功能障碍之间的病理关系尚不明确
临床、遗传和生化证据表明,PERK 臂的信号传导不平衡。
未折叠蛋白反应 (UPR) 会导致与许多疾病相关的神经元功能障碍
神经退行性疾病,包括上面列出的疾病,PERK 整合了转录和翻译。
信号传导促进线粒体蛋白质稳态和功能的适应性重塑以响应急性 ER
然而,为了应对慢性 ER 应激,PERK 通过复杂的机制启动细胞凋亡。
涉及线粒体功能障碍,这引出了一个有趣的问题:“PERK 是如何差异调节的”
线粒体功能响应不同水平的内质网应激的保护性和病理性方面?
PERK 依赖性翻译衰减被证明可促进适应性线粒体伸长
在这里,我们将证明线粒体形态的这种变化对应于急性内质网损伤的反应。
线粒体膜内磷脂的 PERK 依赖性调节。
磷脂与多种神经退行性疾病的发病机制有关。
磷脂是线粒体生物学各个方面的关键调节决定因素,包括形态、
在此,我们检验了 PERK 依赖性调节的假设。
线粒体磷脂促进 ER 期间线粒体膜的适应性重塑
压力以及这种调节的不平衡会导致病理性线粒体功能障碍
结合使用生化、代谢组学和成像技术进行观察。
方法,我们将定义线粒体磷脂的 PERK 依赖性调节的分子基础
并证明了这种调节在决定线粒体形态、嵴超微结构、
通过这些努力,我们将确定 PERK 依赖性调节。
线粒体磷脂作为一种使线粒体适应急性内质网应激的机制。
将表明慢性 PERK 信号传导会诱导线粒体磷脂的病理改变
总的来说,我们的结果将导致与神经变性相关的线粒体功能障碍。
建立线粒体膜磷脂的 PERK 依赖性重塑作为关键决定因素
此外,我们的工作将揭示新的线粒体功能以应对不同水平的内质网应激。
深入了解 PERK 信号传导对线粒体功能障碍的病理和治疗影响
与神经退行性疾病(包括 AD 和相关疾病)的发病机制有关。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Imbalanced unfolded protein response signaling contributes to 1-deoxysphingolipid retinal toxicity.
- DOI:10.1038/s41467-023-39775-w
- 发表时间:2023-07-11
- 期刊:
- 影响因子:16.6
- 作者:Rosarda, Jessica D.;Giles, Sarah;Harkins-Perry, Sarah;Mills, Elizabeth A.;Friedlander, Martin;Wiseman, R. Luke;Eade, Kevin T.
- 通讯作者:Eade, Kevin T.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Rockland Luke Wiseman其他文献
Rockland Luke Wiseman的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Rockland Luke Wiseman', 18)}}的其他基金
Establishing Strategies to Ameliorate Amyloid Pathology in Light Chain Amyloidosis
制定改善轻链淀粉样变性淀粉样蛋白病理学的策略
- 批准号:
10677553 - 财政年份:2016
- 资助金额:
$ 235.62万 - 项目类别:
Establishing Strategies to Ameliorate Amyloid Pathology in Light Chain Amyloidosis
制定改善轻链淀粉样变性淀粉样蛋白病理学的策略
- 批准号:
9270017 - 财政年份:2016
- 资助金额:
$ 235.62万 - 项目类别:
Establishing Strategies to Ameliorate Amyloid Pathology in Light Chain Amyloidosis
制定改善轻链淀粉样变性淀粉样蛋白病理学的策略
- 批准号:
10057800 - 财政年份:2016
- 资助金额:
$ 235.62万 - 项目类别:
Establishing Strategies to Ameliorate Amyloid Pathology in Light Chain Amyloidosis
制定改善轻链淀粉样变性淀粉样蛋白病理学的策略
- 批准号:
9104759 - 财政年份:2016
- 资助金额:
$ 235.62万 - 项目类别:
IMPACTING MITOCHONDRIA FUNCTION THROUGH ALTERED PROTEASE ACTIVITY
通过改变蛋白酶活性影响线粒体功能
- 批准号:
9915982 - 财政年份:2016
- 资助金额:
$ 235.62万 - 项目类别:
IMPACTING MITOCHONDRIA FUNCTION THROUGH ALTERED PROTEASE ACTIVITY
通过改变蛋白酶活性影响线粒体功能
- 批准号:
9078540 - 财政年份:2016
- 资助金额:
$ 235.62万 - 项目类别:
Establishing Strategies to Ameliorate Amyloid Pathology in Light Chain Amyloidosis
制定改善轻链淀粉样变性淀粉样蛋白病理学的策略
- 批准号:
10441391 - 财政年份:2016
- 资助金额:
$ 235.62万 - 项目类别:
Establishing Strategies to Ameliorate Amyloid Pathology in Light Chain Amyloidosis
制定改善轻链淀粉样变性淀粉样蛋白病理学的策略
- 批准号:
10190919 - 财政年份:2016
- 资助金额:
$ 235.62万 - 项目类别:
Direct Regulation of Extracellular Proteostasis by the Unfolded Protein Response
通过未折叠的蛋白质反应直接调节细胞外蛋白质稳态
- 批准号:
9065690 - 财政年份:2015
- 资助金额:
$ 235.62万 - 项目类别:
Direct Regulation of Extracellular Proteostasis by the Unfolded Protein Response
通过未折叠的蛋白质反应直接调节细胞外蛋白质稳态
- 批准号:
8942459 - 财政年份:2015
- 资助金额:
$ 235.62万 - 项目类别:
相似海外基金
The Role of Dopamine in Cognitive Resilience to Alzheimer's Disease Pathology in Healthy Older Adults
多巴胺在健康老年人阿尔茨海默氏病病理认知弹性中的作用
- 批准号:
10678125 - 财政年份:2023
- 资助金额:
$ 235.62万 - 项目类别:
Effects of Aging on Neuronal Lysosomal Damage Responses Driven by CMT2B-linked Rab7
衰老对 CMT2B 相关 Rab7 驱动的神经元溶酶体损伤反应的影响
- 批准号:
10678789 - 财政年份:2023
- 资助金额:
$ 235.62万 - 项目类别:
A Refined Murine Model of Post-sepsis Cognitive Impairment for Investigating Mitochondrial Abnormalities and Human ApoE4 Gene Polymorphisms
用于研究线粒体异常和人类 ApoE4 基因多态性的精制脓毒症后认知障碍小鼠模型
- 批准号:
10646579 - 财政年份:2023
- 资助金额:
$ 235.62万 - 项目类别:
Elucidating endolysosomal trafficking dysregulation induced by APOE4 in human astrocytes
阐明人星形胶质细胞中 APOE4 诱导的内溶酶体运输失调
- 批准号:
10670573 - 财政年份:2023
- 资助金额:
$ 235.62万 - 项目类别:
Impact of TBI and Cognitive Decline on Alzheimer's Disease Brain-Derived Exosome Cargo
TBI 和认知能力下降对阿尔茨海默病脑源性外泌体货物的影响
- 批准号:
10662883 - 财政年份:2023
- 资助金额:
$ 235.62万 - 项目类别: